| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Healthcare sector), SPTX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 16.69M | - | - | |
| 10% | 6.29M | - | - | |
| Dir | 2.73M | - | - | |
| Dir | 863.0K | - | - | |
| Other | 33.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Hombach Robert J. | Director | Buy | 13,000 | $18.14 | $235,768.00 | New | |
| May 4, 2026 | Arch Venture Partners Xii, LLC61 | 10% Owner | Buy | 1,100,000 | $18.00 | $19,800,000.00 | +21.2% |